Evidence map›Paper›PMID 34642385›Full record

ArticleScientific reports2021

Estimated pulse wave velocity improves risk stratification for all-cause mortality in patients with COVID-19.

Kimon Stamatelopoulos, Georgios Georgiopoulos, Kenneth F Baker, Giusy Tiseo, Dimitrios Delialis, Charalampos Lazaridis, Greta Barbieri, Stefano Masi, Nikolaos I Vlachogiannis, Kateryna Sopova and 12 more

Registry-linked trialAbstract read
In one paragraph

Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06836622 (Correlation Between the Values of Carotid-Femoral, Oscillometric and Estimated Pulse Wave Velocity), which is not on this map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06836622 not yet recruitingnot on this mapstarted 2026, after this paper: background citation

Correlation Between the Values of Carotid-Femoral, Oscillometric and Estimated Pulse Wave Velocity

TypeobservationalSponsorHospital de BaseRan2026 to 2027Enrolled350ConditionsHypertension, Arterial Stiffness, Pulse Wave Analysis, Pulse Wave Velocity
3 · Its place in the literature

Who cites it

26 citing papers in PubMed.

  1. Association between high-altitude erythrocytosis and arterial stiffness in long-term high-altitude residents.Hypertension research : official journal of the Japanese Society of Hypertension · 2026
    Article
  2. Review
  3. Observational
  4. Article
  5. Observational
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. (Epi)transcriptomics in cardiovascular and neurological complications of COVID-19.Journal of molecular and cellular cardiology plus · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Kimon Stamatelopoulos *Department of Clinical Therapeutics, National and Kapodistrian University of Athens School of Medicine, Athens, Greece. kstamatel@med.uoa.gr.
Georgios Georgiopoulos *Department of Clinical Therapeutics, National and Kapodistrian University of Athens School of Medicine, Athens, Greece.
Kenneth F Baker *Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.
Giusy TiseoDepartment of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
Dimitrios DelialisDepartment of Clinical Therapeutics, National and Kapodistrian University of Athens School of Medicine, Athens, Greece.
Charalampos LazaridisBiosciences Institute, International Centre for Life, Vascular Biology and Medicine Theme, Faculty of Medical Sciences, Newcastle University, Central Parkway, Newcastle upon Tyne, NE1 3BZ, UK.
Greta BarbieriDepartment of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
Stefano MasiDepartment of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
Nikolaos I VlachogiannisBiosciences Institute, International Centre for Life, Vascular Biology and Medicine Theme, Faculty of Medical Sciences, Newcastle University, Central Parkway, Newcastle upon Tyne, NE1 3BZ, UK.
Kateryna SopovaBiosciences Institute, International Centre for Life, Vascular Biology and Medicine Theme, Faculty of Medical Sciences, Newcastle University, Central Parkway, Newcastle upon Tyne, NE1 3BZ, UK.
Alessandro MengozziDepartment of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
Lorenzo GhiadoniDepartment of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
Ina Schim van der LoeffTranslational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.
Aidan T HanrathTranslational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.
Bajram AjdiniDepartment of Clinical Therapeutics, National and Kapodistrian University of Athens School of Medicine, Athens, Greece.
Charalambos VlachopoulosFirst Department of Cardiology, National and Kapodistrian University of Athens Medical School, Athens, Greece.
Meletios A DimopoulosDepartment of Clinical Therapeutics, National and Kapodistrian University of Athens School of Medicine, Athens, Greece.
Christopher J A DuncanTranslational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.
Marco FalconeDepartment of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
Konstantinos StellosBiosciences Institute, International Centre for Life, Vascular Biology and Medicine Theme, Faculty of Medical Sciences, Newcastle University, Central Parkway, Newcastle upon Tyne, NE1 3BZ, UK. konstantinos.stellos@ncl.ac.uk.
Pisa COVID-19 Research Group
Newcastle COVID-19 Research Group

Funding

European Research CouncilWellcome Trust 211153/Z/18/Z
6 · The paper itself

Abstract

Accurate risk stratification in COVID-19 patients consists a major clinical need to guide therapeutic strategies. We sought to evaluate the prognostic role of estimated pulse wave velocity (ePWV), a marker of arterial stiffness which reflects overall arterial integrity and aging, in risk stratification of hospitalized patients with COVID-19. This retrospective, longitudinal cohort study, analyzed a total population of 1671 subjects consisting of 737 hospitalized COVID-19 patients consecutively recruited from two tertiary centers (Newcastle cohort: n = 471 and Pisa cohort: n = 266) and a non-COVID control cohort (n = 934). Arterial stiffness was calculated using validated formulae for ePWV. ePWV progressively increased across the control group, COVID-19 survivors and deceased patients (adjusted mean increase per group 1.89 m/s, P < 0.001). Using a machine learning approach, ePWV provided incremental prognostic value and improved reclassification for mortality over the core model including age, sex and comorbidities [AUC (core model + ePWV vs. core model) = 0.864 vs. 0.755]. ePWV provided similar prognostic value when pulse pressure or hs-Troponin were added to the core model or over its components including age and mean blood pressure (p < 0.05 for all). The optimal prognostic ePWV value was 13.0 m/s. ePWV conferred additive discrimination (AUC: 0.817 versus 0.779, P < 0.001) and reclassification value (NRI = 0.381, P < 0.001) over the 4C Mortality score, a validated score for predicting mortality in COVID-19 and the Charlson comorbidity index. We suggest that calculation of ePWV, a readily applicable estimation of arterial stiffness, may serve as an additional clinical tool to refine risk stratification of hospitalized patients with COVID-19 beyond established risk factors and scores.

Indexed as

Vascular StiffnessAgedAged, 80 and overCardiovascular DiseasesComorbidityCOVID-19FemaleHumansItalyLongitudinal StudiesMaleMiddle AgedRetrospective StudiesRisk FactorsUnited Kingdom

Identifiers

PMID34642385
PMCPMC8511157

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.